Next Article in Journal
Comment on Anwer et al. Rehabilitation of Upper Limb Motor Impairment in Stroke: A Narrative Review on the Prevalence, Risk Factors, and Economic Statistics of Stroke and State of the Art Therapies. Healthcare 2022, 10, 190
Next Article in Special Issue
Is Piperacillin-Tazobactam an Appropriate Empirical Agent for Hospital-Acquired Sepsis and Community-Acquired Septic Shock of Unknown Origin in Australia?
Previous Article in Journal
Understanding Attitudes, Social Norms, and Behaviors of a Cohort of Post-Operative Nurses Related to Pain and Pain Management
Previous Article in Special Issue
Antimicrobial Resistance, Healthcare-Associated Infections, and Environmental Microbial Contamination
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Controlling Infectious Risk in Transfusion: Assessing the Effectiveness of Skin Disinfection in Blood Donors

1
Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy
2
University Hospital of Sassari, 07100 Sassari, Italy
3
Department of Medical, Surgical and Experimental Sciences, University of Sassari, 07100 Sassari, Italy
*
Author to whom correspondence should be addressed.
Healthcare 2022, 10(5), 845; https://doi.org/10.3390/healthcare10050845
Submission received: 23 March 2022 / Revised: 22 April 2022 / Accepted: 2 May 2022 / Published: 5 May 2022

Abstract

:
Bacterial infectious risk is a major problem in transfusion medicine. The type of micro-organisms isolated during bacterial contamination of blood products indicates that the donor’s skin is its main source. In this context, the primary measures to reduce this risk are: (a) optimal disinfection of the donor’s arm and (b) satellite bag diversion of the initial volume of blood collected. This work aimed to verify the effectiveness of skin disinfection of the blood donor’s venipuncture site. Two methodological approaches were used: (a) qualitative and quantitative microbiological testing of the skin at the collection site, before and post-disinfection; (b) qualitative microbiological testing of the first deviated blood. Pre-disinfection testing showed skin microbial load values between 3 and >200 CFU/plate. More than two-thirds of the isolates were Gram-positive bacteria (77.8%) of which 57.7% were staphylococci. Among Gram-negative bacteria, Pseudomonadaceae, Enterobacteriaceae, and Acinetobacter spp. were isolated from the blood donors (BDs). Post-disinfection, a 100% reduction in microbial load was observed in 84.4% of BDs. Microbiological testing of the first blood diverted sample revealed the presence of microbial flora in 1.9% samples; of the isolates, 83.3% were non-aureus staphylococci. This study highlights the importance of the correct application of skin disinfection procedures in order to ensure blood safety.

1. Introduction

The transfusion of blood and blood components is an essential and irreplaceable therapeutic procedure in the treatment of many pathological conditions. However, like other therapies, it is not without risks of various types. Such risks relate to (i) genetic difference of the transfused blood; (ii) the possibility of adverse events deriving from an interaction between the medical intervention and the individual’s organic equilibrium; (iii) medical error; (iv) the technical and/or administrative errors due to the mistaken application of procedural rules; (v) the possibility of transmission of both infectious and non-infectious diseases [1,2,3,4].
With regard to the risk of transmitting infectious diseases, several strategies, including donor screening and deferral, blood testing, and pathogen inactivation, have resulted in all-time low levels, particularly in developed countries. Nevertheless, while lower than in the past, the bacterial infection risk is still a major problem in transfusion medicine [5,6,7,8,9,10].
Bacterial contamination of blood products can be endogenous in origin, mainly transient donor bacteraemia due to minor chronic infections, asymptomatic infections, and dental procedures, or exogenous due to inadequate disinfection of the skin at the venipuncture site, improper venipuncture technique, presence of a skin tissue plug due to needle insertion, plastic defects in the collection bag, bacterial contamination of anticoagulant and disinfectant, and contamination of the venipuncture needle by the external environment [1,5].
The type of micro-organisms isolated during bacterial contamination indicates that the main source is the donor’s skin [1,5,10,11,12,13,14]. Although under physiological conditions, the skin constitutes a valid barrier to the penetration of micro-organisms into the underlying tissues, any injury that compromises its structural integrity (wounds, needles, catheters, etc.) may constitute a potential entry point for micro-organisms. In this sense, blood sampling is a critical moment during which bacteria present on the skin can pass into the collection system through the phlebotomy needle, through a skin plug punched out by the needle, or through the small skin flaps produced by the needle itself during phlebotomy [15,16,17,18,19,20,21].
In this context, the primary measures to reduce the risk of bacterial contamination of blood products are: (a) optimal disinfection of the donor’s arm to reduce skin microbial load and (b) satellite bag diversion of the initial volume of blood collected in order to remove the first aliquot of donor blood, which may have higher concentrations of skin flora [19,20,22,23].
As several variables can affect the risk of bacterial contamination of the donation product (e.g., type, concentration, and application method of the disinfectant used; contact time of the disinfectant with the skin), the aim of this work was to verify the effectiveness of skin disinfection of the blood donor’s venipuncture site. This study was included in a wide-ranging program of clinical risk surveillance and quality control of care that the Hygiene and Hospital Infection Control Unit of the University Hospital of Sassari (AOU-SS) carries out at the same University Hospital [24,25,26,27,28,29,30].

2. Materials and Methods

2.1. Study Setting

The study was carried out by the operators from the Hospital Hygiene and Infection Control Unit of the AOU-SS at the immunohaematology and transfusion medicine service of the same hospital. This service has an annual average of approximately 8100 donors, 10,380 donations, and 21,850 blood components produced. In accordance with the regulations in force, the age of donors is between 18 and 65, and the act of donating is voluntary and unpaid.

2.2. Assessing Skin Disinfection

In Italy, the National Blood Centre, given Legislative Decree no. 208 of 9 November 2007, issued its ‘Guidelines for the prevention of bacterial contamination of whole blood and blood components’. In addition to reiterating the procedures for skin disinfection, these guidelines provide for the sole use of collection systems that enable the deviation of the first volume of blood from the donation to be used for the performance of the diagnostic tests laid out in the ministerial provisions [31,32]. Because of this, the effectiveness of skin disinfection was assessed in this study during a 5 year period on at least 1% of the donations, using two different approaches: (a) directly, by qualitative and quantitative microbiological testing of the skin at the collection site, before and after disinfection (donor arm testing); (b) indirectly, by qualitative microbiological testing of the portion of blood destined for the satellite bag (first diverted blood); this blood was taken from donors different from group a. In both groups, the donors or the donation product (first diverted blood) were consecutively selected; first the donation products, and subsequently, the donors from those present at the time of testing.

2.3. Qualitative and Quantitative Microbiological Testing of Skin

BDs were recruited after medical screening and a brief explanation of the purpose of the study. Microbiological testing of the donor skin was performed immediately before and after disinfection of the skin in the venipuncture site. Disinfection was carried out according to protocol using chlorhexidine 2%. For this purpose, 55 mm diameter RODAC (replicate organism detection and counting) contact plates containing plate count agar (PCA) medium with a neutralising agent (Tween 80) to inhibit the residual activity of the disinfectant were placed on the blood sampling area, exerting constant pressure for 40 s. The plates were then incubated in an incubator at 36 ± 1 °C for 48 h. After this time, the microbial load was determined, the micro-organisms isolated were identified, and for staphylococci only, the sensitivity to methicillin was tested. With regard to microbial load determination, when the number of colonies grown was such that they almost completely or completely covered the surface of the culture medium, the result of the count was expressed as >200 CFU/plate [33].
The efficacy of skin disinfection was assessed both quantitatively and qualitatively.
With regard to the quantitative evaluation, the efficacy of skin disinfection was calculated as the percentage of CFU reduction in post-disinfection vs. CFU detected in pre-disinfection. In particular, the reduction was calculated as 1 − (XCFU post/XCFU pre) ∗ 100, where XCFU post is the number of CFU observed post-disinfection, and XCFU pre is the number of CFU observed before the skin disinfection.
As regards the qualitative evaluation, the proportion of non-effectiveness (i.e., positivity with at least 1 CFU/plate post-disinfection) was determined for each quartile of subjects observed sorted by pre-disinfection skin microbial load.
As the qualitative and quantitative characterisation of the microbial flora present on the skin in the venipuncture site prior to disinfection is instrumental in identifying individual and environmental factors that may influence the varying degree of skin contamination, and possibly, the efficacy of disinfection itself, the results on the microbial flora present pre-disinfection on donors’ skin were processed according to the variables sex, age, and season.

2.4. Qualitative Microbiological Testing of the First Portion of Diverted Blood Intended for Satellite Bag

Testing of the first diverted blood was performed using the BACTEC 9240 automated blood culture system (Becton Dickinson Company, Franklin Lakes, NJ, USA; http://legacy.bd.com/ds/technicalCenter/clsi/clsi-9000bc2.pdf, accessed on 22 April 2022). Under aseptic conditions, two aliquots of blood destined for the satellite bag (approximately 10 mL each) were inoculated into the anaerobic culture bottle (the first) and the aerobic culture bottle (the second). The inoculated culture bottles were placed in the BACTEC 9240 system for incubation at 35 ± 1.5 °C with continuous agitation. This system tracks the amount and rate of CO2 production, indicative of microbial growth. Culture bottles that produced a positive result were subcultured onto blood agar plates to isolate microbial colonies for identification and methicillin susceptibility testing (staphylococci only). Culture bottles in which no growth was detected were removed from the automated system after 7 days, according to the manufacturer’s instructions.

2.5. Statistical Analysis

Data were entered on Excel (Microsoft Office, Microsoft Corporation, Redmond, WA, USA) and analysed using the STATA software 16.1 (StatCorp., Austin, TX, USA). Quantitative variables were expressed as the mean ± standard deviation and range or as median and interquartile range (IQR), categorical variables as proportions.
The difference among groups as regards the microbial load was tested using the rank-based nonparametric Kruskal-Wallis H test (KW). The relationship between variables was calculated using the kernel nonparametric regression model. The independent variables (sex and season) were categorised in ascending order based on the average bacterial load values recorded.
Data were sorted according to pre-disinfection skin microbial load and divided into quartiles. The first quartile (i.e., 25th percentile) and the third quartile (i.e., 75th percentile) were calculated and are indicated in tables as Q1 and Q3, respectively. The qualitative evaluation of the efficacy of disinfection in relation to skin microbial load was performed using trend analysis for proportions.
Prevalence and 95% confidence intervals were reported as percentages. Differences among proportions were tested with the z-test. A two-tailed p-value of less than 0.05 was considered statistically significant.

3. Results

The adequacy and effectiveness of the disinfection procedure was assessed (a) directly, by microbiological testing of the skin in the blood collection area of 330 donors immediately before and after disinfection, and (b) indirectly, by testing the first blood diverted in 267 satellite bags.

3.1. Microbiological Testing of Skin before and after Antisepsis

A total of 330 donors aged 18–65 years were recruited (mean age 45.3 ± 11.4; median age 46; IQR 17), of whom one-third (110/330; 33.3%) were aged 46–55 years. The prevailing sex was male (229/330; 69.4%). Of the tests, 26.4% (87/330) were performed in winter (January–March). The distribution of BDs by age group, sex, and season is shown in Table 1.
Pre-disinfection testing showed skin microbial load values between 3 and >200 CFU/plate (median 47; IQR 60), the latter being observed in 15.8% of donors (52/330). The distribution of microbial load values showed no significant difference between age groups (KW: chi-squared 171 = 4.148; p = 0.386) but the highest median values were in the 26–35 age group (median 57; IQR 56.25) and the lowest in the 36–45 age group (median 41; 170 IQR 56) (Table 2). In relation to the seasons, the difference in the microbial load detected was not statistically significant (KW: chi-squared = 2.798; p = 0.4239) (Table 2).
When analysing the microbial load values both by age group and season, the highest median values were observed in spring in the age group 26–35 and in winter in the age group 46–55 (Table 2).
The microbial load values in male donors ranged from 3 CFU/plate to >200 CFU/plate (median value 46 CFU/plate; IQR 60), without statistically significant differences between age groups (KW: chi-squared = 2.698; p = 0.609) (Table 3). In female donors, the same values ranged from 4 CFU/plate to >200 CFU/plate (median value 47 CFU/plate; IQR 68), without statistically significant differences among age groups (KW: chi-squared = 2.747; p = 0.601) (Table 3). The median values of microbial load between sexes, 46 and 47 CFU/plate for male and female donors, respectively, did not differ statistically significantly (KW: chi-squared = 0.058; p = 0.81).
Overall, the distribution by sex, age, and season showed the highest median values in male donors in spring in the 26–35 age group and in female donors in spring in the 18–25 age group and in winter in the 56–65 age group, where in one female donor each season, a microbial load >200 CFU/plate was recorded.
The results of the nonparametric kernel regression analysis to assess the association between the bacterial load found and the dependent variables (sex, age, and season) are shown in Table 4.
As Table 4 shows, the bacterial load increased with age and female sex, with differences between seasons, although not statistically significant.
Qualitatively, more than two-thirds of the isolates (522/671) were Gram-positive bacteria (77.8%; 95% CI: 77.5–81.0), of which 57.7% (301/522; 95% CI: 53.5–61.9) were staphylococci. Additionally, 11% (33/301; 95% CI: 7.5–14.5) of the staphylococci were Staphylococcus aureus, of which 9.1% (3/33; 95% CI: 7.1–18. 9) were methicillin-resistant (methicillin-resistant Staphylococcus aureus, MRSA); methicillin resistance was also detected in 3.4% (9/268; 95% CI: 1.2–5.6) of the non-aureus (coagulase-negative) staphylococci. Among Gram-negatives, the most frequently isolated micro-organisms were Pseudomonadaceae (51/149; 34.2%; 95% CI: 43.0–59.0) (Figure 1).
Efficacy was assessed both as a percentage of load reduction pre- and post-disinfection and in relation to initial load values.
As regards the percentage of reduction, tests carried out after disinfection showed a 100% reduction in microbial load in 280 out of 330 donors (84.8%; 95% CI: 80.9–88.7); the remaining 50 donors (15.2%; 95% CI: 11.3–19.1) had microbial load values between 1 and 28 CFU/plate, with a percentage reduction in microbial load ranging from 71.9% to 99.5% (mean percentage reduction 93.7% (95% CI: 86.9–100.0)).
The efficacy of skin disinfection was evaluated in relation to the pre-disinfection microbial load (Table 5).
As the table shows, the proportion of non-effectiveness increased significantly in accordance with the microbial load found pre-disinfection.
Among the micro-organisms isolated, 91.5% (54/59; 95% CI: 84.4–98.6) were Gram-positive, predominantly staphylococci (35/59; 59.3% of the total; 95% CI: 46.8–71.8), all coagulase-negative, of which 1 (2.9%) was methicillin-resistant. Among the 5 Gram-negative isolates, there was an Enterobacteriaceaea (Proteus spp.).

3.2. Microbiological Testing of First Diverted Blood

Testing was performed on 267 donations. Microbial flora was detected in five samples (1.9%; 95% CI: 0.3–3.5); 83.3% of the isolates were non-aureus staphylococci, all of which were methicillin-sensitive.

4. Discussion

Microbiological testing of the skin prior to disinfection revealed a bacterial colonisation of the skin that varied both quantitatively, with microbial load values between 3 and >200 CFU/plate, and to a lesser extent, qualitatively, with different bacterial species isolated. In addition to the more common skin flora, Staphylococcus aureus, Enterobacteriaceae, and Pseudomonadaceae were isolated. These micro-organisms, especially Enterobacteriaceae and Staphylococcus aureus, are considered to be among the most undesirable contaminants of blood products on the basis of clinical observations and their virulence characteristics [34,35,36]. In addition, some methicillin-resistant strains of staphylococci have been reported, confirming their presence in hospital and community settings [37,38,39].
The analysis of skin microbial load values by sex, age, and season of donation, independently for each variable, indicated that female donors, the 26–35 age group, and the autumn and winter seasons were the most critical factors.
Conversely, other authors have observed that intrinsic factors, such as sex and age, and extrinsic factors, such as environmental characteristics (e.g., climate), can influence the quality and quantity of the skin microbial flora, so that the highest values can likely be expected in men (physiological sex differences affecting skin properties include hormone production, sweating rate, sebum production, surface pH, skin thickness, etc.), summer (higher exposure and skin moisture), and older age groups, as it is known that surface flora increases with age [12,15,18,40,41]. Our findings did not confirm these figures. However, the differences we observed were not significant.
The disinfection resulted in a reduction in the baseline microbial load ranging from 71.9% to 100%, the latter observed in approximately 85% of donors. Even if the probability of non-effectiveness was significantly associated with the extent of baseline contamination but not with the type of antiseptic used (always chlorhexidine 2%), the variability observed may have been influenced by human factors, i.e., the operator performing antisepsis. An optimal disinfection also depends on the way in which the disinfectant is applied. The positive result of the microbiological tests on the first blood diverted confirmed the importance of this procedure, since even after disinfection was performed, the possibility of contamination of the blood remained (we found it in 1.9% of the cases). Although careful antisepsis can significantly reduce the amount of micro-organisms present on the superficial layers of the skin, it cannot act as effectively on the deeper layers [32,42]. Therefore, the collection bag can be contaminated when the needle is inserted [17]. However, the absence of contamination in more than 98% of the tests confirmed the indispensability of an effective and properly performed skin disinfection.

5. Conclusions

The donor plays a major role in transfusion. If on the one hand, they provide the product to be transfused, on the other hand, they are required to ensure that this product is as safe as possible. In this context, the adoption of correct lifestyles and the willingness to exclude oneself in the event of risky conditions and/or behaviour, alongside attention to one’s personal hygiene, are of paramount importance. Careful cleaning of the donor (especially the arm) and clothing can lead to a reduction in skin contamination, thereby also favouring the effectiveness of the disinfection procedure. Our results highlighted that a possible failure of disinfection depends on the initial load.
The disinfection procedure plays a crucial role in preventing the risk of bacterial contamination of blood donations and must be carried out with the utmost care on each donor, even the last of a successful day’s donations. The choice of disinfectant and the duration of its application are essential factors that can reduce the risk of bacterial contamination from the skin flora, and as such, the healthcare worker who takes the blood sample must also adopt suitable behaviours that favours the effectiveness of disinfection, which include carefully washing hands before the procedure and respecting the timing and method of application of the disinfectant.
It is with this in mind that awareness-raising and training activities should be directed towards healthcare workers—useful in all clinical risk training contexts—and towards those citizens who, through a voluntary and unpaid act, ensure the availability of that most precious commodity, blood.

Author Contributions

Conceptualization, A.A. (Antonella Arghittu), M.D., P.C. and M.D.M.; data curation, A.A. (Antonella Arghittu), M.D., G.M.D., S.S., A.P., G.D., A.A. (Antonio Azara) and M.D.M.; formal analysis, M.D., G.D. and M.D.M.; investigation, A.A. (Antonella Arghittu), G.M.D., P.C.M., A.A.C., I.C. and A.P.; methodology, A.A. (Antonella Arghittu), M.D., P.C. and M.D.M.; software, M.D. and P.C.; supervision, P.C. and M.D.M.; validation, M.D.M.; writing—original draft, A.A. (Antonella Arghittu), G.M.D., S.S., A.P., G.D., A.A. (Antonio Azara) and M.D.M.; writing—review & editing, M.D., P.C. and M.D.M. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by “Fondo di Ateneo per la Ricerca 2020”, University of Sassari.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on reasonable request from the corresponding author.

Acknowledgments

The authors would like to thank Emma Dempsey for the English language revision.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Allain, J.P.; Bianco, C.; Blajchman, M.A.; Brecher, M.E.; Busch, M.; Leiby, D.; Lin, L.; Stramer, S. Protecting the blood supply from emerging pathogens: The role of pathogen inactivation. Transfus. Med. Rev. 2005, 19, 110–126. [Google Scholar] [CrossRef] [PubMed]
  2. Aprili, G. Safety in transfusion medicine. Blood Transfus. 2008, 6, 121–126. [Google Scholar] [CrossRef] [PubMed]
  3. Roberts, D.J.; Field, S.; Delaney, M.; Bates, I. Problems and Approaches for Blood Transfusion in the Developing Countries. Hematol. Oncol. Clin. N. Am. 2016, 30, 477–495. [Google Scholar] [CrossRef] [PubMed]
  4. Kleinman, S.; Chan, P.; Robillard, P. Risks associated with transfusion of cellular blood components in Canada. Transfus. Med. Rev. 2003, 17, 120–162. [Google Scholar] [CrossRef] [PubMed]
  5. Patel, T.G.; Shukla, R.V.; Gupte, S.C. Impact of donor arm cleaning with different aseptic solutions for prevention of contamination in blood bags. Indian J. Hematol. Blood Transfus. 2013, 29, 17–20. [Google Scholar] [CrossRef] [Green Version]
  6. Webster, J.; Bell-Syer, S.E.; Foxlee, R. Skin preparation with alcohol versus alcohol followed by any antiseptic for preventing bacteraemia or contamination of blood for transfusion. Cochrane Database Syst. Rev. 2015, 2015, CD007948. [Google Scholar] [CrossRef] [Green Version]
  7. Weimer, A.; Tagny, C.; Tapko, J.; Gouws, C.; Tobian, A.; Ness, P.; Bloch, E. Blood transfusion safety in sub-Saharan Africa: A literature review of changes and challenges in the 21st century. Transfusion 2019, 59, 412–427. [Google Scholar] [CrossRef] [Green Version]
  8. El Mehdaoui, F.; Benajiba, M.; Boulahdid, S.; El Hattimy, F.; Soulaymani, A.; Alami, R. Skin flora and bacterial contamination of diversion pouch and recovered platelet components in Moroccan blood donors. Transfus. Med. 2020, 30, 384–390. [Google Scholar] [CrossRef]
  9. Morel, P.; Deschaseaux, M.; Bertrand, X.; Nagelen, C.; des Floris, M.F.L.; Bardiaux, L. Maîtrise du risque bactérien transfusionnel en France en 2013. Transfus. Clin. Biol. 2013, 20, 174–181. [Google Scholar] [CrossRef]
  10. McDonald, C.P. Bacterial risk reduction by improved donor arm disinfection, diversion and bacterial screening. Transfus. Med. 2006, 16, 381–396. [Google Scholar] [CrossRef]
  11. Liumbruno, G.M.; Catalano, L.; Piccinini, V.; Pupella, S.; Grazzini, G. Reduction of the risk of bacterial contamination of blood components through diversion of the first part of the donation of blood and blood components. Blood Transfus. 2009, 7, 86–93. [Google Scholar] [CrossRef] [PubMed]
  12. Vasconcelos, E.; Seghatchian, J. Bacterial contamination in blood components and preventative strategies: An overview. Transfus. Apher. Sci. 2004, 31, 155–163. [Google Scholar] [CrossRef] [PubMed]
  13. Blajchman, M.A.; Beckers, E.A.; Dickmeiss, E.; Lin, L.; Moore, G.; Muylle, L. Bacterial detection of platelets: Current problems and possible resolutions. Transfus. Med. Rev. 2005, 19, 259–272. [Google Scholar] [CrossRef] [PubMed]
  14. Schmidt, M. Bacterial contamination of blood products. ISBT Sci. Ser. 2013, 8, 177–180. [Google Scholar] [CrossRef]
  15. Cundell, A.M. Microbial Ecology of the Human Skin. Microb. Ecol. 2018, 76, 113–120. [Google Scholar] [CrossRef]
  16. Lanciotti, E. Microbiota dell’uomo, epidemiologia e accertamento diagnostico delle infezioni. In Biologia e Microbiologia Sanitaria; Zanichelli Editore: Bologna, Italy, 2002. [Google Scholar]
  17. Gibson, T.; Norris, W. Skin fragments removed by injection needles. Lancet 1958, 2, 983–985. [Google Scholar] [CrossRef]
  18. Pastila, S.; Lönnroth, M.; Heikkilä, R.; Heikkilä, H.; Carlson, P. Bacterial skin flora and contamination of blood components: Do we defer blood donors wisely? Vox Sang. 2012, 103, 93–98. [Google Scholar] [CrossRef]
  19. Wagner, S.J.; Robinette, D.; Friedman, L.I.; Miripol, J. Diversion of initial blood flow to prevent whole-blood contamination by skin surface bacteria: An in vitro model. Transfusion 2000, 40, 335–338. [Google Scholar] [CrossRef]
  20. Ramirez-Arcos, S.; Goldman, M. Skin disinfection methods: Prospective evaluation and postimplementation results. Transfusion 2010, 50, 59–64. [Google Scholar] [CrossRef]
  21. Levy, J.H.; Neal, M.D.; Herman, J.H. Bacterial contamination of platelets for transfusion: Strategies for prevention. Crit. Care 2018, 22, 271. [Google Scholar] [CrossRef] [Green Version]
  22. McDonald, C.P.; Roy, A.; Mahajan, P.; Smith, R.; Charlett, A.; Barbara, J.A. Relative values of the interventions of diversion and improved donor-arm disinfection to reduce the bacterial risk from blood transfusion. Vox Sang. 2004, 86, 178–182. [Google Scholar] [CrossRef]
  23. De Korte, D.; Marcelis, J.H.; Verhoeven, A.J.; Soeterboek, A.M. Diversion of first blood volume results in a reduction of bacterial contamination for whole-blood collections. Vox Sang. 2002, 83, 13–16. [Google Scholar] [CrossRef] [PubMed]
  24. Masia, M.D.; Dettori, M.; Deriu, G.M.; Bellu, S.; Arcadu, L.; Azara, A.; Piana, A.; Palmieri, A.; Arghittu, A.; Castiglia, P. ATP Bioluminescence for Assessing the Efficacy of the Manual Cleaning Procedure during the Reprocessing of Reusable Surgical Instruments. Healthcare 2021, 9, 352. [Google Scholar] [CrossRef] [PubMed]
  25. Masia, M.D.; Dettori, M.; Deriu, G.M.; Soddu, S.; Deriu, M.; Arghittu, A.; Azara, A.; Castiglia, P. Microbial Monitoring as a Tool for Preventing Infectious Risk in the Operating Room: Results of 10 Years of Activity. Atmosphere 2021, 12, 19. [Google Scholar] [CrossRef]
  26. Dettori, M.; Arghittu, A.; Deiana, G.; Azara, A.; Masia, M.D.; Palmieri, A.; Spano, A.L.; Serra, A.; Castiglia, P. Influenza Vaccination Strategies in Healthcare Workers: A Cohort Study (2018–2021) in an Italian University Hospital. Vaccines 2021, 9, 971. [Google Scholar] [CrossRef]
  27. Deiana, G.; Arghittu, A.; Dettori, M.; Masia, M.D.; Deriu, M.G.; Piana, A.; Muroni, M.R.; Castiglia, P.; Azara, A. Environmental Surveillance of Legionella spp. in an Italian University Hospital Results of 10 Years of Analysis. Water 2021, 13, 2304. [Google Scholar] [CrossRef]
  28. Stefanelli, P.; Bellino, S.; Fiore, S.; Fontana, S.; Amato, C.; Buttinelli, G. Hospital discharges-based search of acute flaccid paralysis cases 2007–2016 in Italy and comparison with the National Surveillance System for monitoring the risk of polio reintroduction. BMC Public Health 2019, 19, 1532. [Google Scholar] [CrossRef]
  29. Deiana, G.; Dettori, M.; Masia, M.D.; Spano, A.L.; Piana, A.; Arghittu, A.; Castiglia, P.; Azara, A. Monitoring Radon Levels in Hospital Environments. Findings of a Preliminary Study in the University Hospital of Sassari, Italy. Environments 2021, 8, 28. [Google Scholar] [CrossRef]
  30. Deiana, G.; Arghittu, A.; Dettori, M.; Deriu, M.G.; Palmieri, A.; Azara, A.; Castiglia, P.; Masia, M.D. Ten-Year Evaluation of Thermal Comfort in Operating Rooms. Healthcare 2022, 10, 307. [Google Scholar] [CrossRef]
  31. Decreto Legislativo 6 Novembre 2007, n. 208. “Attuazione Della Direttiva 2005/62/CE Che Applica la Direttiva 2002/98/CE Per Quanto Riguarda le Norme e le Specifiche Comunitarie Relative ad un Sistema di Qualita’ Per i Servizi Trasfusionali “Pubblicato nella Gazzetta Ufficiale n. 261 del 9 Novembre 2007—Supplemento Ordinario n. 228. Gazzetta Ufficiale della Repubblica Italiana. Available online: https://web.camera.it/parlam/leggi/deleghe/07208dl.htm (accessed on 28 February 2022).
  32. Centro Nazionale Sangue. Linee Guida Per la Prevenzione Della Contaminazione Batterica del Sangue Intero e Degli Emocomponenti. Available online: https://www.salute.gov.it/imgs/C_17_pubblicazioni_1716_allegato.pdf (accessed on 28 February 2022).
  33. Anzidei, P.; Frusteri, L.; Giovinazzo, R.; Guerrera, E.; Sarto, D.; Todaro, N.; Venanzetti, F. “Il Monitoraggio Microbiologico Negli Ambienti di Lavoro” Edizione 2005 dell’ INAIL. Available online: http://www.sabbatiniconsulting.com/DOCUMENTAZIONE/DOC1/07%20AGENTI%20BIOLOGICI/30%20Modalita%20di%20monitoraggio%20biologico.pdf (accessed on 20 February 2022).
  34. Palavecino, E.L.; Yomtovian, R.A.; Jacobs, M.R. Bacterial contamination of platelets. Transfus. Apher. Sci. 2010, 42, 71–82. [Google Scholar] [CrossRef]
  35. Walther-Wenke, G. Incidence of bacterial transmission and transfusion reactions by blood components. Clin. Chem. Lab. Med. 2008, 46, 919–925. [Google Scholar] [CrossRef] [PubMed]
  36. Klausen, S.S.; Hervig, T.; Seghatchian, J.; Reikvam, H. Bacterial contamination of blood components: Norwegian strategies in identifying donors with higher risk of inducing septic transfusion reactions in recipients. Transfus. Apher. Sci. 2014, 51, 97–102. [Google Scholar] [CrossRef] [PubMed]
  37. Johnson, A.P. Methicillin-resistant Staphylococcus aureus: The European landscape. J. Antimicrob. Chemother. 2011, 66 (Suppl. 4), iv43–iv48. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Natsis, N.E.; Cohen, P.R. Coagulase-Negative Staphylococcus Skin and Soft Tissue Infections. Am. J. Clin. Dermatol. 2018, 19, 671–677. [Google Scholar] [CrossRef]
  39. Laupland, K.B.; Ross, T.; Gregson, D.B. Staphylococcus aureus bloodstream infections: Risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000–2006. J. Infect. Dis. 2008, 198, 336–343. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  40. Morel, P.; Deschaseaux, M.; Bertrand, X.; Naegelen, C.; Talon, D. Transfusion et bactéries: Risque résiduel et perspectives de prévention. Transfus. Clin. Biol. 2003, 10, 192–200. [Google Scholar] [CrossRef]
  41. Kong, H.H.; Segre, J.A. Skin microbiome: Looking back to move forward. J. Investig. Dermatol. 2012, 132 Pt 2, 933–939. [Google Scholar] [CrossRef] [Green Version]
  42. Wagner, S.J. Transfusion-transmitted bacterial infection: Risks, sources and interventions. Vox Sang. 2004, 86, 157–163. [Google Scholar] [CrossRef]
Figure 1. Qualitative aspects of pre-disinfection skin microbial contamination.
Figure 1. Qualitative aspects of pre-disinfection skin microbial contamination.
Healthcare 10 00845 g001
Table 1. Distribution of BDs by age group, sex, and season.
Table 1. Distribution of BDs by age group, sex, and season.
Age GroupsWinterSpringSummerAutumnTotal for Age Groups
BDsMFBDsMFBDsMFBDsMFBDs
18–2544054165162421
26–35159611831385115650
36–452315818144161152618883
46–5528208282172921825169110
56–65171611610617134169766
Total for season876423785721815823845034330
BDs = Blood Donors; M = Male; F = Female.
Table 2. The distribution of microbial load before skin disinfection in different age groups and seasons.
Table 2. The distribution of microbial load before skin disinfection in different age groups and seasons.
Age GroupsWinterSpringSummerAutumnTotal for Age Groups
CFU Median
(Q1–Q3)
CFU Median
(Q1–Q3)
CFU Median
(Q1–Q3)
CFU Median
(Q1–Q3)
CFU Median
(Q1–Q3)
18–2543
(31.25–52.75)
78
(42–>200)
42.5
(33.5–56.75)
26
(15.25–39)
42
(30–67)
26–3552
(32–92)
88
(47.5–>200)
52
(36–72)
56
(33–65.5)
57
(38–94.25)
36–4548
(30.5–101.5)
36.5
(23.5–59)
39
(23.75–76.25)
52.5
(28.25–86.75)
41
(27–83)
46–5579
(31–129.75)
37.5
(23.25–67.25)
40
(24–62)
57
(26–119)
42.5
(26–97)
56–6547
(40–87)
35
(27.5–51.5)
35
(28–56)
48
(36.5–116)
45
(28.25–69.25)
Total for season52
(31.5–99.5)
42
(27.25–80.25)
42
(28–68)
50.5
(27.75–92)
47
(28–88)
Table 3. Distribution of BDs’ pre-disinfection microbial load (median, Q1 and Q3 CFU/Plate) by age group and season.
Table 3. Distribution of BDs’ pre-disinfection microbial load (median, Q1 and Q3 CFU/Plate) by age group and season.
Age GroupsWinterSpringSummerAutumnTotal for Age Groups
CFU Median
(Q1–Q3)
CFU Median
(Q1–Q3)
CFU Median
(Q1–Q3)
CFU Median
(Q1–Q3)
CFU Median
(Q1–Q3)
Male donors
18–2543
(31.25–52.75)
60
(40.5–108.75)
47
(38–60)
21.5
(17.25–25.75)
42
(34–63.5)
26–3552
(38–88)
108
(63–>200)
53.5
(32–79.5)
41
(28–58)
59
(38.75–98.5)
36–4548
(35–101.5)
36.5
(23.5–59)
57
(24.5–84.5)
54.5
(29.75–86.75)
44.5
(27–84)
46–5579.5
(31–100)
42
(24–67)
40
(28–62)
47.5
(26–98.75)
42
(26–93.5)
56–6547
(39.25–72)
29.5
(23–42)
32
(28–56)
49
(38–116)
41
(28–64)
Total for season50
(34.5–95)
42
(26–81)
44.5
(28–68)
45.5
(27.25–91)
46
(28–88)
Female donors
18–25->200
(ND)
7
(ND)
32
(19.75–59)
32
(15.25–93)
26–3558.5
(28.75–89.75)
47
(41.5–124)
52
(48–72)
57
(42.5–81.25)
54
(37.5–90.75)
36–4546
(28.75–117)
39
(27.25–50.25)
37
(24–41)
47
(23.5–81)
41
(28–67)
46–5556.5
(28.5–>200)
33
(21–65)
41.5
(14–86.25)
62
(38–>200)
47.5
(24–>200)
56–65>200
(ND)
47.5
(35–162.75)
44
(28.25–56)
47
(32–100.5)
47.5
(32–108.25)
Total for season61
(28.5–192)
47
(31–68)
41
(22–59)
54.5
(28.75–104.75)
47
(28–96)
ND = not determined. Single value (single donor) by age group in the season.
Table 4. Results of kernel nonparametric regression between pre-disinfection skin microbial load and age, season, and sex.
Table 4. Results of kernel nonparametric regression between pre-disinfection skin microbial load and age, season, and sex.
Pre-DisinfectionObserved EstimateBootstrap Std. Err.zp-Value95% Confidence Interval
Mean Microbial load71.474053.98530817.930.00064.3859379.83375
Effect
age0.03501030.33071990.110.916−0.69650350.6905527
Season
(2 vs. 1)3.4541627.5497860.460.647−12.6601118.50325
(3 vs. 1)10.293549.0471161.140.255−9.00431127.59761
(4 vs. 1)14.7869411.397951.300.195−7.86345536.94938
Sex
(F vs. M)7.0088798.4989450.820.410−9.28740123.64976
1 = summer; 2 = spring; 3 = autumn; 4 = winter.
Table 5. Loss of disinfection effectiveness as a function of microbial load: trend of proportions.
Table 5. Loss of disinfection effectiveness as a function of microbial load: trend of proportions.
Pre-Disinfection Quartiles *
(a)
No. of Positive Plates **
(b)
Proportion
(b/a)
Chi-Squared
for Trend
p-Value
1st (n. = 82)40.04916.8010.0000
2nd (n. = 83)100.120
3rd (n. = 82)130.159
4th (n. = 83)230.277
* Pre-disinfection skin microbial load ordered into quartiles (83 observations per quartile). ** at least 1 CFU/plate post-disinfection.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Arghittu, A.; Dettori, M.; Deriu, G.M.; Soddu, S.; Manca, P.C.; Carboni, A.A.; Collu, I.; Palmieri, A.; Deiana, G.; Azara, A.; et al. Controlling Infectious Risk in Transfusion: Assessing the Effectiveness of Skin Disinfection in Blood Donors. Healthcare 2022, 10, 845. https://doi.org/10.3390/healthcare10050845

AMA Style

Arghittu A, Dettori M, Deriu GM, Soddu S, Manca PC, Carboni AA, Collu I, Palmieri A, Deiana G, Azara A, et al. Controlling Infectious Risk in Transfusion: Assessing the Effectiveness of Skin Disinfection in Blood Donors. Healthcare. 2022; 10(5):845. https://doi.org/10.3390/healthcare10050845

Chicago/Turabian Style

Arghittu, Antonella, Marco Dettori, Grazia Maria Deriu, Serena Soddu, Pietro Carmelo Manca, Anna Angela Carboni, Irene Collu, Alessandra Palmieri, Giovanna Deiana, Antonio Azara, and et al. 2022. "Controlling Infectious Risk in Transfusion: Assessing the Effectiveness of Skin Disinfection in Blood Donors" Healthcare 10, no. 5: 845. https://doi.org/10.3390/healthcare10050845

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop